Na Zhang
Changping, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.
Journal: Nature
Published: May 02, 2023
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
Journal: Nature
Published: September 23, 2022
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75.
Journal: Cell host & microbe
Published: August 15, 2022
Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants.
Journal: The Lancet. Infectious diseases
Published: August 10, 2022
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Journal: Nature
Published: April 30, 2022
Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage.
Journal: Bioorganic chemistry
Published: January 12, 2021
Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR.
Journal: Acta pharmaceutica Sinica. B
Published: December 28, 2020
Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5.
Journal: Acta pharmaceutica Sinica. B
Published: March 26, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026